These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12851039)

  • 1. Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects.
    Webber C; Roth A; Persiani S; Peard AJ; Makovec F; Kapil RP; John BA; Holding JD; D'amato M; Cybulski ZR; Chasseaud LF; Rovati LC
    Xenobiotica; 2003 Jun; 33(6):625-41. PubMed ID: 12851039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the rat.
    Webber C; Stokes CA; Persiani S; Makovec F; McBurney A; Kapil RP; John BA; Houchen TL; D'Amato M; Chasseaud LF
    Eur J Drug Metab Pharmacokinet; 2003; 28(3):201-12. PubMed ID: 14527093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the dog.
    Webber C; Stokes CA; Persiani S; Makovec F; McBurney A; Kapil RP; John BA; D'Amato M; Chasseaud LF
    Eur J Drug Metab Pharmacokinet; 2004; 29(1):15-23. PubMed ID: 15151166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic profile of dexloxiglumide.
    Persiani S; D'Amato M; Jakate A; Roy P; Wangsa J; Kapil R; Rovati LC
    Clin Pharmacokinet; 2006; 45(12):1177-88. PubMed ID: 17112294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The single-dose pharmacokinetics of the novel CCK1 receptor antagonist, dexloxiglumide, are not influenced by age and gender.
    Roy P; Wangsa J; Patel A; Nolting A; Persiani S; Abramowitz W; Kapil R
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):444-51. PubMed ID: 16163898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of the anti-oestrogen droloxifene in female human subjects.
    John BA; Brodie RR; Baldock GA; McBurney A; Chasseaud LF; Jank P; Von Nieciecki A
    Xenobiotica; 2002 Aug; 32(8):699-713. PubMed ID: 12296990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide.
    Jakate AS; Roy P; Patel A; Abramowitz W; Persiani S; Wangsa J; Kapil R
    Br J Clin Pharmacol; 2005 Nov; 60(5):498-507. PubMed ID: 16236040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.
    Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C
    Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of multiple-dose dexloxiglumide on the pharmacokinetics of oral contraceptives in healthy women.
    Roy P; Jakate AS; Patel A; Abramowitz W; Wangsa J; Persiani S; Kapil R
    J Clin Pharmacol; 2005 Mar; 45(3):329-36. PubMed ID: 15703367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects.
    Gerisch M; Hafner FT; Lang D; Radtke M; Diefenbach K; Cleton A; Lettieri J
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):195-206. PubMed ID: 29188322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
    Paulson SK; Zhang JY; Breau AP; Hribar JD; Liu NW; Jessen SM; Lawal YM; Cogburn JN; Gresk CJ; Markos CS; Maziasz TJ; Schoenhard GL; Burton EG
    Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.